Error: Could not add to watchlist. X
+ Watchlist

Geron Corp

GERN:US
NASDAQ GS
1.99
USD
0.04
1.97%
As of 8:10 PM EDT 8/21/2017
Open
2.02
Day Range
1.98 - 2.05
Volume
1,341,522
Previous Close
2.03
52Wk Range
1.81 - 3.15
1 Yr Return
-27.37%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
2.02
Day Range
1.98 - 2.05
Volume
1,341,522
Previous Close
2.03
52Wk Range
1.81 - 3.15
1 Yr Return
-27.37%
YTD Return
-3.86%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.16
Market Cap (m USD)
316.835
Shares Outstanding (m)
159.214
Price/Sales (TTM)
53.56
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.46%
% Price Change
+0.49%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, and in hematologic myeloid malignancies.
Address
149 Commonwealth Drive
Suite 2070
Menlo Park, CA 94025
United States
Phone
1-650-473-7700
Show More